Mutual Aid-Science Community Convention

Post time 2023-2-10 11:55:00

https://doi.org/10.1038/s41561-023-01136-z

Please :)

Post time 2023-2-10 13:39:34

Dear Admin, Hope all are well there. It will of great help if you kindly send me the following article doi.org/10.1016/j.compbiomed.2022.106311.
Thanks and regards

Post time 2023-2-10 21:21:24

Post time 2023-2-10 21:21:49

Post time 2023-2-10 21:23:18

Post time 2023-2-10 21:57:29

Dear admin,
I hope you are doing well and safe, my collogues and I would really appreciate if we will be able to access these research articles:

https://doi.org/10.1016/j.addma.2021.102517
https://doi.org/10.1016/j.msea.2022.143818
https://doi.org/10.1016/j.msea.2022.143167

Thankew

Post time 2023-2-11 09:49:18

https://doi.org/10.1016/j.purol.2021.12.010 please help me to get this article

Post time 2023-2-11 09:51:17

https://doi.org/10.1016/j.purol.2021.12.010 please help me to get this article

Post time 2023-2-12 02:03:17

Dear team,

Could you please help me with an access to this article https://doi.org/10.1002/9781119757153.ch19
Cannot open it with sci-hub

Thanks in advance!

Post time 2023-2-12 17:18:02

MERCI DE POUVOIR M'AIDER A OBTENIR CET ARTICLE Doi : AE-06-2007-68-S1-0003-4266-101019-200703126
Trois études dans le diabète de type 2 : ADOPT La rosiglitazone en monothérapie dans le diabète de type 2 : quelle est sa place ? - 16/02/08
Doi : AE-06-2007-68-S1-0003-4266-101019-200703126
R. Roussel

Mutual Aid-Science Community Convention

Reply

Questions

Latest Reply

Announcement

Daily Top Contributors

Mutual Aid-Science Community Convention Copy

Reply

Questions

Latest Reply

Announcement

Daily Top Contributors

Mutual Aid-Science Community Convention